Jay Shepard

Jay P.
Shepard was the founder of Relypsa, Inc., founded in 2007, serving as Director from 2008 to 2010.
Mr. Shepard was also the founder of Pathalys Pharma, Inc...
Current positions included Independent Director at Esperion Therapeutics, Inc. since 2018; Independent Director at Ironwood Pharmaceuticals, Inc. since 2020; Director at Santa Clara University; Independent Director at Inovio Pharmaceuticals, Inc. since 2020; Director at Craig Hospital; Independent Director at Altamont Pharma Acquisition Corp.; Outside Director at Aculys Pharma LLC; Director at Cessation Therapeutics, LLC; and Venture Partner at Catalys Pacific LLC.
Former positions include President, Chief Executive Officer & Director at NextWave Pharmaceuticals, Inc. from 2011 to 2012; President, Chief Executive Officer & Director at Ilypsa, Inc. from 2005 to 2008; President, CEO, CFO & Director at Versartis, Inc. from 2017 to 2018; Chairman at Aravive, Inc. in 2020; Director at InterMune, Inc.; Independent Director at DURECT Corp.; Independent Director at Immedica Pharma US, Inc.; Director at Sorbent Therapeutics, Inc.; Director at Bullet Biotechnology, Inc.; Director at Christopher & Dana Reeve Foundation from 2016 to 2020; Director at NeuroRecovery Technologies, Inc.; Vice President at ALZA Corp.; Vice President-Commercial Operations at Telik, Inc. from 2001 to 2005; Executive Partner at Sofinnova Investments, Inc. from 2008 to 2015; Principal at Syntex Laboratories, Inc.; Vice President-Oncology Business Unit at ALZA Pharmaceuticals from 1993 to 2000; Principal at Ortho Pharmaceutical Corp.; Executive Partner at Sofinnova Ventures from 2008 to 2015.
Education includes undergraduate studies at the University of Arizona.